US 12,679,897 B2 · Monoclonal antibodies to fibroblast growth factor receptor 2

Abstract

The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Claims3

Dependent claims

A pharmaceutical composition comprising the antibody produced by the hybridoma deposited as ATCC PTA-9586.

Dependencies are inferred from the claim text.

Facts

Application

18/182,242Filed 10 Mar 2023 · continuation

Priority

7 Nov 2008

Published

US 2023/0242650 A13 Aug 2023

Granted

14 Jul 2026

Term ends

Not estimatedThe source records don’t support an estimate.

Classification16 codes

C07K 16/2863
Against receptors, cell surface antigens or cell surface determinants: against receptors for growth factors, growth regulators
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…
A61P 35/00
Antineoplastic agents

Family

Application61/112,686Us provisional application · filed 7 Nov 2008

Application61/164,870Us provisional application · filed 30 Mar 2009

Application12/614,282Parent of this division · filed 6 Nov 2009

Application13/284,838Parent of this continuation · filed 28 Oct 2011

US 8,101,723 B2Parent of this division · filed 24 Jan 2012

Application14/071,520Parent of this continuation · filed 4 Nov 2013

US 8,603,987 B2Parent of this continuation · filed 10 Dec 2013

Application15/172,033Parent of this continuation · filed 2 Jun 2016

US 9,382,324 B2Parent of this continuation · filed 5 Jul 2016

Application15/674,385Parent of this continuation · filed 10 Aug 2017

US 9,834,609 B2Parent of this continuation · filed 5 Dec 2017

Application16/164,530Parent of this continuation · filed 18 Oct 2018

US 10,138,301 B2Parent of this continuation · filed 27 Nov 2018

Application16/867,398Parent of this continuation · filed 5 May 2020

US 10,689,448 B2Parent of this continuation · filed 23 Jun 2020

US 2023/0242650 A1Pre-grant publication · published 3 Aug 2023

Application13/284,838Parent of this division

US 2010/0196364 A1Published application

US 2012/0134994 A1Published application

US 2014/0193899 A1Published application

US 2016/0362496 A1Published application

US 2018/0094063 A1Published application

US 2019/0153105 A1Published application

US 2020/0347141 A1Published application

US 12,679,897 B2This patent

From the US filing history. Foreign family members aren’t listed.